eIND submission for the PB004 project and further development of PB003G towards Phase 0

Pure Biologics submits an eIND application to the FDA for the start of Phase 0 in the PB004 project and decides on the further development of PB003G toward Phase 0.

News

Inquiries

Dr. Pieter Spee is the new Chief Scientific Officer

1 June

2021

Dr. Pieter Spee is the new Chief Scientific Officer

Dr. Pieter Spee, a medical biologist and manager with many years of experience in international biopharmaceutical companies, was appointed to the position of Chief Scientific Officer, CSO.

Recommendations for the Pure Biologics company shares

26 May

2021

Recommendations for the Pure Biologics company shares

Dom Maklerski BOŚ recommends the purchase of Pure Biologics shares.

Pure Biologics teams up with Twist Bioscience

15 April

2021

Pure Biologics teams up with Twist Bioscience

Pure Biologics joins efforts with Twist Bioscience to expand the capabilities of the phage display technology used in Pure Biologics' portfolio of immuno-oncology projects.